Terns Pharmaceuticals Inc (NASDAQ: TERN) started the day on Wednesday, with a price decrease of -15.29% at $5.76, before settling in for the price of $6.80 at the close. Taking a more long-term approach, TERN posted a 52-week range of $4.32-$11.40.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been -20.00% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -12.40%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 6.25%. This publicly-traded company’s shares outstanding now amounts to $84.92 million, simultaneously with a float of $62.28 million. The organization now has a market capitalization sitting at $489.24 million. At the time of writing, stock’s 50-day Moving Average stood at $6.77, while the 200-day Moving Average is $7.06.
Terns Pharmaceuticals Inc (TERN) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Terns Pharmaceuticals Inc’s current insider ownership accounts for 26.68%, in contrast to 71.52% institutional ownership. According to the most recent insider trade that took place on Dec 05 ’24, this organization’s Chief Executive Officer bought 15,450 shares at the rate of 7.15, making the entire transaction reach 110,468 in total value, affecting insider ownership by 19,099. Preceding that transaction, on Sep 12 ’24, Company’s Director bought 476,190 for 10.50, making the whole transaction’s value amount to 4,999,995. This particular insider is now the holder of 476,190 in total.
Terns Pharmaceuticals Inc (TERN) Earnings and Revenue Records
Terns Pharmaceuticals Inc’s EPS increase for this current 12-month fiscal period is 6.25% and is forecasted to reach -1.32 in the upcoming year.
Terns Pharmaceuticals Inc (NASDAQ: TERN) Trading Performance Indicators
Let’s observe the current performance indicators for Terns Pharmaceuticals Inc (TERN). It’s Quick Ratio in the last reported quarter now stands at 32.99. The Stock has managed to achieve an average true range (ATR) of 0.51.
In the same vein, TERN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.18, a figure that is expected to reach -0.30 in the next quarter, and analysts are predicting that it will be -1.32 at the market close of one year from today.
Technical Analysis of Terns Pharmaceuticals Inc (TERN)
If we take a close look at the recent performances of Terns Pharmaceuticals Inc (NASDAQ: TERN), its last 5-days Average volume was 2.0 million that shows progress from its year to date volume of 1.34 million. During the previous 9 days, stock’s Stochastic %D was recorded 42.26% While, its Average True Range was 0.53.
Raw Stochastic average of Terns Pharmaceuticals Inc (TERN) in the period of the previous 100 days is set at 5.05%, which indicates a major rise in contrast to 3.41% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 99.93% that was higher than 80.38% volatility it exhibited in the past 100-days period.
